TYPE 1 diabetes (T1D), affecting approximately 150,000 Australians, has long been considered incurable, but is about to get a major boost in the form of a Federal Government research grant of $9.46m.
The project will be run by St Vincent's Institute of Medical Research in Melbourne and headed by Professor Thomas Kay, will focus on three intersecting themes.
Firstly, it will focus on early life and understanding why T1D develops.
Secondly, it will investigate prevention and seek to identify new drugs to stop the disease from occurring.
Thirdly, it will explore treatment, aiming to improve therapies to replace the cells that are destroyed during the disease process.
Visit nhmrc.gov.au for details.
The above article was sent to subscribers in Pharmacy Daily's issue from 16 Nov 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Nov 17